Gilder Gagnon Howe & Co’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-6,022	Closed	-$135K	–	278
2018 Q1	$135K	Sell	6,022 -106,604	-95%	-$2.95M	﹤0.01%	268
2017 Q4	$3.39M	Sell	112,626 -10,545	-9%	-$337K	0.05%	180
2017 Q3	$4.64M	Buy	123,171 +111,982	+1,001%	+$3.64M	0.07%	151
2017 Q2	$312K	Buy	11,189 +2,243	+25%	+$66.8K	﹤0.01%	232
2017 Q1	$308K	Buy	8,946 +7,975	+821%	+$282K	0.01%	228
2016 Q4	$28K	Sell	971 -4,658	-83%	-$123K	﹤0.01%	258
2016 Q3	$179K	Buy	5,629 +990	+21%	+$33.6K	﹤0.01%	233
2016 Q2	$151K	Sell	4,639 -32	-0.7%	-$1.07K	﹤0.01%	237
2016 Q1	$131K	Sell	4,671 -134,363	-97%	-$2.93M	﹤0.01%	207
2015 Q4	$4.96M	Sell	139,034 -168,797	-55%	-$5.95M	0.08%	122
2015 Q3	$10.2M	Sell	307,831 -3,353	-1%	-$140K	0.16%	100
2015 Q2	$13M	Sell	311,184 -6,051	-2%	-$234K	0.17%	93
2015 Q1	$10.3M	Sell	317,235 -1,357,327	-81%	-$46.7M	0.14%	101
2014 Q4	$53.2M	Sell	1,674,562 -14,327	-0.8%	-$406K	0.79%	39
2014 Q3	$41.8M	Sell	1,688,889 -23,164	-1%	-$542K	0.61%	48
2014 Q2	$38.7M	Sell	1,712,053 -397,311	-19%	-$8.29M	0.51%	51
2014 Q1	$51.3M	Buy	2,109,364 +49,835	+2%	+$1.26M	0.7%	47
2013 Q4	$51.5M	Buy	2,059,529 +380,353	+23%	+$8.97M	0.73%	40
2013 Q3	$46.1M	Sell	1,679,176 -26,332	-2%	-$550K	0.72%	46
2013 Q2	$31M	Buy	+1,705,508	New	+$23.5M	0.58%	53